Intra-Cellular Therapies
ITCI
#1825
Rank
โ‚ฌ8.67 B
Marketcap
81,85ย โ‚ฌ
Share price
0.28%
Change (1 day)
50.23%
Change (1 year)

Intra-Cellular Therapies (ITCI) - Cash on Hand

Cash on Hand as of September 2024 : โ‚ฌ0.96 Billion

According to Intra-Cellular Therapies's latest financial reports the company has โ‚ฌ0.96 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Intra-Cellular Therapies - Cash on Hand chart (from 2013 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31โ‚ฌ0.45 B-18.37%
2022-12-31โ‚ฌ0.55 B51.56%
2021-12-31โ‚ฌ0.36 B-31.88%
2020-12-31โ‚ฌ0.53 B167.3%
2019-12-31โ‚ฌ0.19 B-34.17%
2018-12-31โ‚ฌ0.30 B-21.5%
2017-12-31โ‚ฌ0.38 B5.98%
2016-12-31โ‚ฌ0.36 B-15.98%
2015-12-31โ‚ฌ0.43 B307.71%
2014-12-31โ‚ฌ0.10 B296.26%
2013-12-31โ‚ฌ26.9 M85.86%
2013-03-31โ‚ฌ0 M
2012-12-31โ‚ฌ14.47 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
โ‚ฌ42.35 M-95.60%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ27.08 M-97.18%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.51 B-46.06%๐Ÿ‡บ๐Ÿ‡ธ USA